Outsourcing

Articles

The acquisition will give the CDMO additional clinical filling options in Europe, which is expected to come online in 2021.

Vetter Expands Fill/Finish Capacity with Acquisition of New Site in Austria

HHS announces $354 million in funding for private industry to manufacture generic drugs in the US from raw materials to finished product.

BARDA Funds US-based Drug Manufacturing Initiative

Catalent and Johnson & Johnson announce joint investment and tech transfer to prepare for rapid scale-up and segregated cGMP commercial manufacturing capacity.

Catalent to Manufacture J&J’s Lead COVID-19 Vaccine Candidate

Catalent Biologics increased capacity at its Bloomington, IN Facility.

Catalent Expands Biologics Packaging Capacity

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Civica Rx plans redundant manufacturing capacity to relieve and prevent shortages of generic, sterile injectable drugs. 

Addressing Drug Shortages

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Considering the potential interaction of a drug with the delivery device early on in in development is integral to achieving the best combination.

Avoiding Negative Drug–Device Interactions

The new molecules entering the development pipeline are bringing forth exciting challenges in drug delivery.

Delivering the Goods

Understanding of scale-up parameters and use of process analytical technology are important to meet demand for larger batch sizes.

Challenges in Clinical Manufacturing for Topical Drugs

Kai Vogt is senior vice-president Corporate Development, Legal and Compliance, Information Technology at Vetter Pharma. 

CDMOs must consider challenges associated with the complexity of contract pharmaceutical manufacturing when approaching digitalization projects. 

Digitalization: A CDMO’s Perspective

Phillips-Medisize has announced  that it is expanding its current Global Innovation and Development (GID) site in Struer, Denmark, to include a dedicated manufacturing development and clinical build unit.


Contract Manufacturing, Finished Drug Product